Ming Liang Cheng

US Patent:

8071383, Dec 6, 2011

Filed:

Mar 16, 2007

Appl. No.:

12/293161

Inventors:

Diana Arias - Cary NC, US
Sara Price - Raleigh NC, US
Leslie Grist - Raleigh NC, US
Ming Cheng - Cary NC, US
Haiping Hong - Morrisville NC, US
Libby Bernal - Durham NC, US
Paula Olhoft - Morrisville NC, US
Hee-Sook Song - Raleigh NC, US
Luke Mankin - Raleigh NC, US

Assignee:

BASF Plant Science GmbH - Ludwigshafen

International Classification:

C12N 15/82
C12N 15/90
A01H 5/00

US Classification:

435468, 4353201, 435419, 800288

Abstract:

The present invention relates to improved methods and means for transformation of soybean () based on a D-alanine and/or D-serine selection.

US Patent:

8076142, Dec 13, 2011

Filed:

Dec 11, 2007

Appl. No.:

12/001234

Inventors:

Xiang Huang - Apex NC, US
Ming Cheng - Cary NC, US
Haiping Hong - Morrisville NC, US
Yan Liu - Chapel Hill NC, US
Kangfeng Mei - Apex NC, US

Assignee:

BASF Plant Sciences GmbH

International Classification:

C12N 15/82
C12N 5/04
A01H 5/00

US Classification:

435469, 435419, 800294, 8003172, 800312, 8003174

Abstract:

Disclosed herein are rooted plant assay systems, methods of making rooted plant assay systems, and methods of using rooted plant assay systems for high throughput screening of test polynucleotides for their ability to effect phenotypic traits having agricultural value.

US Patent:

20200023001, Jan 23, 2020

Filed:

Jul 19, 2019

Appl. No.:

16/517274

Inventors:

- Boston MA, US
Solomon A. Mensah - Malden MA, US
Ming Cheng - Boston MA, US
Ronodeep Mitra - Boston MA, US

International Classification:

A61K 31/737
A61K 31/661
A61K 9/00
A61P 9/10

Abstract:

Provided herein are compositions comprising heparan sulfate, or a pharmaceutically acceptable salt thereof, and sphingosine-1-phosphate, or a pharmaceutically acceptable salt thereof. Such compositions are useful in a variety of methods, including methods of regenerating endothelial glycocalyx, preventing endothelial glycocalyx degradation and treating vascular disease.

US Patent:

20180127503, May 10, 2018

Filed:

Mar 10, 2016

Appl. No.:

15/555036

Inventors:

- Emeryville CA, US
- New York NY, US
Pei WANG - Union City CA, US
Nai-Kong CHEUNG - Purchase NY, US
Hongfen GUO - Forest Hills NY, US
Ming CHENG - Roosevelt Island NY, US

International Classification:

C07K 16/28
C07K 16/22
A61K 47/68
A61P 35/00

Abstract:

The invention relates to antibodies, and in particular, to antibodies exhibiting specificity for Receptor tyrosine kinase-like Orphan Receptors (ROR), and to uses thereof for example in the treatment of cancer. The invention extends to polynucleotide and polypeptide sequences encoding the antibodies, and therapeutic uses thereof, and to diagnostic kits comprising these molecules. The invention also extends to antibody-drug conjugates and to uses thereof in therapy.